Drug Insight: rituximab in renal disease and transplantation
- 1 April 2006
- journal article
- review article
- Published by Springer Nature in Nature Clinical Practice Nephrology
- Vol. 2 (4) , 221-230
- https://doi.org/10.1038/ncpneph0133
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Treatment of Vascular Rejection With Rituximab in Cardiac TransplantationThe Journal of Heart and Lung Transplantation, 2005
- Rituximab in childhood systemic lupus erythematosus refractory to conventional immunosuppressionPediatric Nephrology, 2005
- Rituximab Induced Remission in a Patient with Wegener’s GranulomatosisNephron Clinical Practice, 2005
- Anti-CD20 monoclonal antibody for the treatment of refractory autoimmune haemolytic anaemia associated with idiopathic membranous nephropathyRheumatology, 2005
- Refractory acute kidney transplant rejection with CD20 graft infiltrates and successful therapy with rituximabClinical Transplantation, 2004
- Successful resumption of epoetin alfa after rituximab treatment in a patient with pure red cell aplasiaAmerican Journal of Kidney Diseases, 2004
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- Preconditioning regimen consisting of anti‐CD20 monoclonal antibody infusions, splenectomy and DFPP‐enabled non‐responders to undergo ABO‐incompatible kidney transplantationClinical Transplantation, 2004
- Efficacy and safety of rituximab in type II mixed cryoglobulinemiaBlood, 2003
- Successful A1-to-O ABO-incompatible kidney transplantation after a preconditioning regimen consisting of anti-CD20 monoclonal antibody infusions, splenectomy, and double-filtration plasmapheresisTransplantation, 2002